Emily Montal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Emily Montal has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Richard M. White
University of Oxford 4 Ludwig Cancer Research, Nuffield Department of Medicine Oxford, United Kingdom
59 shared publications - Yilun Ma
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center
57 shared publications - Shruthy Suresh
Department of Molecular Biology, UT Southwestern Medical Center, Dallas, Texas
53 shared publications - Dianne Lumaquin
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center
52 shared publications - Ting-Hsiang Huang
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center
52 shared publications - Miranda Victoria Hunter
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center
51 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Restraint of melanoma progression by cells in the local skin environment
Keratinocytes, the dominant cell type in the melanoma microenvironment during tumor initiation, exhibit diverse effects on melanoma progression. Using a zebrafish model of melanoma and human cell co-cultures, we observed that keratinocytes undergo an epithelial-mesenchymal transition (EMT)-like transformation in the presence of melanoma, reminiscent of their behavior during wound healing. Surprisingly, overexpression of the EMT-transcription factor Twist in keratinocytes led to improved overall survival in zebrafish melanoma models, despite no change in tumor initiation rates. This survival benefit was attributed to reduced melanoma invasion, as confirmed by human cell co-culture assays. Single-cell RNA-sequencing revealed a unique melanoma cell cluster in the Twist-overexpressing condition, exhibiting a more differentiated, less invasive phenotype. Further analysis nominated homotypic jam3b–jam3b and pgrn–sort1a interactions between Twist-overexpressing keratinocytes and melanoma cells as potential mediators of the invasive restraint. Our findings suggest that EMT in the tumor microenvironment may paradoxically limit melanoma invasion through altered cell–cell interactions.
- 30 June 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessRestraint of melanoma progression by cells in the local skin environment
Keratinocytes, the dominant cell type in the melanoma microenvironment during tumor initiation, exhibit diverse effects on melanoma progression. Using a zebrafish model of melanoma and human cell co-cultures, we observed that keratinocytes undergo an epithelial-mesenchymal transition (EMT)-like transformation in the presence of melanoma, reminiscent of their behavior during wound healing. Surprisingly, overexpression of the EMT-transcription factor Twist in keratinocytes led to improved overall survival in zebrafish melanoma models, despite no change in tumor initiation rates. This survival benefit was attributed to reduced melanoma invasion, as confirmed by human cell co-culture assays. Single-cell RNA-sequencing revealed a unique melanoma cell cluster in the Twist-overexpressing condition, exhibiting a more differentiated, less invasive phenotype. Further analysis nominated homotypic jam3b–jam3b and pgrn–sort1a interactions between Twist-overexpressing keratinocytes and melanoma cells as potential mediators of the invasive restraint. Our findings suggest that EMT in the tumor microenvironment may paradoxically limit melanoma invasion through altered cell–cell interactions.
- Open Access
- 28 May 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Restraint of melanoma progression by cells in the local skin environment
Keratinocytes, the dominant cell type in the melanoma microenvironment during tumor initiation, exhibit diverse effects on melanoma progression. Using a zebrafish model of melanoma and human cell co-cultures, we observed that keratinocytes undergo an EMT-like transformation in the presence of melanoma, reminiscent of their behavior during wound healing. Surprisingly, overexpression of the EMT transcription factor Twist in keratinocytes led to improved overall survival in zebrafish melanoma models, despite no change in tumor initiation rates. This survival benefit was attributed to reduced melanoma invasion, as confirmed by human cell co-culture assays. Single-cell RNA-sequencing revealed a unique melanoma cell cluster in the Twist-overexpressing condition, exhibiting a more differentiated, less invasive phenotype. Further analysis nominated homotypic jam3b-jam3b and pgrn-sort1a interactions between Twist-overexpressing keratinocytes and melanoma cells as potential mediators of the invasive restraint. Our findings suggest that EMT in the tumor microenvironment may paradoxically limit melanoma invasion through altered cell-cell interactions.
- 28 May 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Open AccessRestraint of melanoma progression by cells in the local skin environment
Keratinocytes, the dominant cell type in the melanoma microenvironment during tumor initiation, exhibit diverse effects on melanoma progression. Using a zebrafish model of melanoma and human cell co-cultures, we observed that keratinocytes undergo an EMT-like transformation in the presence of melanoma, reminiscent of their behavior during wound healing. Surprisingly, overexpression of the EMT transcription factor Twist in keratinocytes led to improved overall survival in zebrafish melanoma models, despite no change in tumor initiation rates. This survival benefit was attributed to reduced melanoma invasion, as confirmed by human cell co-culture assays. Single-cell RNA-sequencing revealed a unique melanoma cell cluster in the Twist-overexpressing condition, exhibiting a more differentiated, less invasive phenotype. Further analysis nominated homotypic jam3b-jam3b and pgrn-sort1a interactions between Twist-overexpressing keratinocytes and melanoma cells as potential mediators of the invasive restraint. Our findings suggest that EMT in the tumor microenvironment may paradoxically limit melanoma invasion through altered cell-cell interactions.
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supp Table S5 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supplementary Table S5. Normalized Counts of transcripts in GRAMD1B KO and NT cells.
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Table S5 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supplementary Table S5. Normalized Counts of transcripts in GRAMD1B KO and NT cells.
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supp Table S6 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp Table S6 Differentially Expressed Genes
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Table S6 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp Table S6 Differentially Expressed Genes
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supp Table S3 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp Table S3 has a List of Oligonucleotides Sequences
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Table S3 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp Table S3 has a List of Oligonucleotides Sequences
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supp Table S4 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp Table S4 has a list of antibodies and other resources
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Table S4 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp Table S4 has a list of antibodies and other resources
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Validation of gramd1b depletion in zebrafish cells and tumors.
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Validation of gramd1b depletion in zebrafish cells and tumors.
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp. Fig. S5 shows that GRAMD1B is a metastasis suppressor in human melanoma
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supp. Fig. S5 shows that GRAMD1B is a metastasis suppressor in human melanoma
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
The AVAST-M trial identifies a signature predictive of metastatic relapse
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
The AVAST-M trial identifies a signature predictive of metastatic relapse
- Open Access
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Supp Table S1 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supplementary Table S1. List of genes predictive of metastasis from AVAST-M trial.
- 10 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupp Table S1 from Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
Supplementary Table S1. List of genes predictive of metastasis from AVAST-M trial.